Results 271 to 280 of about 77,446 (306)

Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in The Netherlands. [PDF]

Eur Heart J Qual Care Clin Outcomes
Fiolet ATL, Keusters W, Blokzijl J, Nidorf SM, Eikelboom JW, Budgeon CA, Tijssen JGP, Römer T, Westendorp I, Cornel JH, Thompson PL, Frederix GWJ, Mosterd A, de Wit GA.   +13 more
europepmc   +1 more source

Fucoxanthin Ameliorates Kidney Injury by CCl₄-Induced via Inhibiting Oxidative Stress, Suppressing Ferroptosis, and Modulating Gut Microbiota. [PDF]

ACS Omega
Ding Y, Ye J, Liu Y, Zhang S, Xu Y, Yang Z, Liu Z.   +6 more
europepmc   +1 more source

Unexpectedly high prevalence of familial Mediterranean fever in Slovakia. [PDF]

Clin Exp Med
Jesenak M, Jurkova EM, Bobcakova A, Hrubiskova K, Petrovicova O, Kapustova L, Kosturiak R, Dallos T, Markocsy A.   +8 more
europepmc   +1 more source

Moxibustion inhibits inflammation in monosodium urate crystal-induced gouty arthritis model rats through metabolomic regulation. [PDF]

Front Mol Biosci
Xie Y, Chen Y, Qin T, Li J, Chang Z, Li Y, Zhang J, Liu M, Wang J, Ren R, Qian Z, Liu J, Chen M.   +12 more
europepmc   +1 more source

Efficacy of Colchicine for Secondary Prevention of Stroke: A Systematic Review and Meta-Analysis of Randomized Control Trials. [PDF]

Cureus
Tabowei G, Faiza Rauf H, Dhungana M, Awais M, Blair K, Chaudhari SS, Habib I, Amin A.   +7 more
europepmc   +1 more source

Clinical characteristics and quality of life in children with PFAPA syndrome and Behçet's disease. [PDF]

Rheumatol Adv Pract
Gürel Bedir A, Kilic SS.
europepmc   +1 more source

Colchicine: A Dual Therapeutic Target for Trichinellosis. [PDF]

Acta Parasitol
Hamed EFA, Taha AA, Ghany SMA, Al-Attar AR, Fawzy EM.   +4 more
europepmc   +1 more source

Colchicine in dermatology [PDF]

Journal of the American Academy of Dermatology, 1998
Colchicine is a medication most often used to treat symptoms of gout. This drug has also been shown to have beneficial effects on cutaneous conditions, including leukocytoclastic vasculitis, psoriasis, and Sweet's syndrome. Colchicine inhibits the function of polymorphonuclear leukocytes, and dermatoses with a strong presence of these cells may benefit
Lloyd E. King, Tory P. Sullivan, Alan S. Boyd   +2 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.

European Heart Journal, 2021
AIMS Recent randomized trials demonstrated a benefit of low-dose colchicine added to guideline-based treatment in patients with recent myocardial infarction or chronic coronary disease.
A. Fiolet, T. Opstal, A. Mosterd, J. Eikelboom, S. Jolly, A. Keech, P. Kelly, D. Tong, J. Layland, S. Nidorf, P. Thompson, C. Budgeon, J. Tijssen, J. Cornel   +13 more
semanticscholar   +1 more source

Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials

Journal of Cardiovascular Medicine, 2021
Supplemental Digital Content is available in the text Aims Colchicine has an emerging role in the cardiovascular field, although, concerns for side effects, especially gastrointestinal, limit its prescription. We aimed at evaluating reported side effects
A. Andreis, M. Imazio, S. Avondo, M. Casula, Elena Paneva, F. Piroli, G. D. de Ferrari   +6 more
semanticscholar   +1 more source